Summary of product characteristics and patient leaflet will be available here:
https://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=63247409

Any report of an adverse reaction related to a Vectans Pharma drug should be made immediately by e-mail to vectansPV@pharmya.com